Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Breast Neoplasms × Mesna × Clear all

Phase

Phase 1/2 4 Phase 2 3 Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia 3 Sarcoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Neuroectodermal Tumors, Primitive, Peripheral 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Myeloid, Acute 1 Leukemia, Monocytic, Acute 1 Leukemia, Megakaryoblastic, Acute 1 Leukemia, Erythroblastic, Acute 1 Ependymoma 1 Central Nervous System Neoplasms 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

Cyclophosphamide 128 Docetaxel 120 Paclitaxel 108 Trastuzumab 100 Tamoxifen 90 Capecitabine 88 Letrozole 76 Epirubicin 62 Doxorubicin 60 exemestane 55 Anastrozole 53 Fulvestrant 52 Radiotherapy 51 Fluorouracil 50 pertuzumab 32 Gemcitabine 30 Vinorelbine 28 Goserelin 28 Carboplatin 28 Chemotherapy, Adjuvant 26 Zoledronic Acid 24 Methotrexate 24 Lapatinib 23 Bevacizumab 22 eribulin 21 ribociclib 19 palbociclib 19 abemaciclib 17 Aromatase Inhibitors 17 130-nm albumin-bound paclitaxel 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00002784 2013-04-04

15-95

ETOP IBCSG Partners Foundation

Phase 3 Completed

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡